In a case series conducted back in 2014, 10 out of 13 newborns had shown hematological abnormalities, including anemia, thrombocytopenia, and leukocytosis with exposure to NAT during the third trimester of pregnancy. This evidence concerns the gene BRD2 and Thrombocytopenia.